$4.87
-0.08-1.62%
Last update: 12:29 PM
15 minutes delayed
Verve Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Verve Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.59 | $-0.68 | 13.2 % |
Mar 2024 | 2024-05-08 | $-0.59 | $-0.71 | 16.9 % |
Dec 2023 | 2024-02-27 | $-0.69 | $-0.82 | 15.8 % |
Sep 2023 | 2023-11-07 | $-0.72 | $-0.92 | 21.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $6.69M | $2.40M | 178.8 % |
Mar 2024 | 2024-05-08 | $5.70M | $2.02M | 181.9 % |
Dec 2023 | 2024-02-27 | $5.14M | $1.17M | 339.6 % |
Sep 2023 | 2023-11-07 | $3.12M | $960.00K | 224.7 % |
Verve Therapeutics (VERV) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.59, which beat the estimate of $-0.68.
The Actual Revenue was $6.7M, which beat the estimate of $2.4M.
Browse earnings estimates, EPS, and revenue on all stocks.